Device / Technology News

RSS

Terumo announces global commercial launch of K-Pack Embrace™ active safety needle

Terumo Corporation today announced the global commercial launch of its K-Pack Embrace™ active safety needle.

From Terumo Corporation 6 Oct 2026

£80 m challenge for faster, better dementia diagnosis launched

The Dementia Challenge is accelerating the adoption of innovative technologies and practices that will diagnose and predict how the disease will progress.

6 Oct 2026

New insights into fetal DNA could improve prenatal testing

Understanding how fetal DNA travels in a pregnant woman’s blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances today.

6 Oct 2026

Electronic sensor detects early Parkinson’s markers in blood

Researchers at King Abdullah University of Science and Technology (KAUST) in collaboration with the University of Oxford have developed a blood-based electronic sensor capable of detecting molecular signatures associated with Parkinson’s disease.

6 Oct 2026

Terumo Blood and Cell Technologies partners with TrAMPoline Pharma to automate TIL therapy manufacturing for solid tumors

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies worldwide, has entered a research collaboration with TrAMPoline Pharma and Eduardo Davila, PhD, at the University of Colorado to develop an automated manufacturing approach for tumor-infiltrating lymphocyte (TIL) therapies targeting solid tumors.

6 Oct 2026

Social media and AI chatbots face gaps in supporting vulnerable users

Two new studies highlight how communication gaps can complicate efforts to protect vulnerable users of technologies such as social media and AI chatbots. Researchers will present the work at the 29th ACM Conference on Computer-Supported Cooperative Work and Social Computing (CSCW 2026), held October 1–14 in Salt Lake City.

6 Oct 2026

Global experts call for coordinated action on digital health risks

The way digital technologies are currently built and governed creates real risks to health worldwide, alongside genuine benefits, according to a new three paper Series authored by 13 global experts, published in The Lancet.

5 Oct 2026

AAP issues guidance for safe and equitable pediatric use of generative AI

The American Academy of Pediatrics has published guidance for pediatricians on the safe, equitable, and effective use of generative artificial intelligence (AI), acknowledging that the rapidly emerging tools offer both promise and risk.

5 Oct 2026

New workflow rapidly identifies deadly fungal bloodstream infections

Bloodstream infections are a persistent threat to hospitalized patients, and those caused by fungi are particularly dangerous. Candida species are responsible for most invasive fungal infections worldwide and rank among the leading causes of hospital-acquired bloodstream infections overall.

5 Oct 2026

Aston University partners with Globe Biomedical to test smart myopia-monitoring eyewear

Aston University School of Optometry and Globe Biomedical have announced a research collaboration for Blink Frames, Globe Biomedical's smart eyewear platform, which continually monitors a patient's eyes via normal-looking spectacle frames.

5 Oct 2026

New AI system automates classification of skin lesions

Skin cancer is a global health challenge, with nearly 1.5 million new cases diagnosed in 2024 according to World Health Organization (WHO) data. In response, the University of Alicante (UA) and the Sant Joan d'Alacant University Hospital have collaborated to launch MEL-IA (MobilE skin Lesion dIAgnosis), an artificial intelligence system designed to automate the classification of skin lesions.

5 Oct 2026

Doctors faced an AI-use penalty after disclosing AI use to patients

A study reveals that AI use by doctors can lead to negative perceptions, especially among younger patients, impacting trust and willingness to follow advice.

5 Oct 2026

Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027

o2h co-discovery has announced that the Cambridge × London Life Sciences Showcase will return for its second edition during J.P. Morgan Healthcare Week 2027 in San Francisco.

From o2h Group 5 Oct 2026

Gut mRNA tech supercharges vaccine and GLP-1 delivery

From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go.

5 Oct 2026

Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research in Nature Biotechnology describing an improved calibration framework for deep learning-based genetic perturbation models.

From Shift Bioscience 5 Oct 2026

CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium

CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more confident decision-making, today announced the full scientific program for the 2026 'From Insight to Decision' e-Symposium.

From CN Bio 5 Oct 2026

MedPharm inks deal to support global pharmaceutical company with commercial site transfer

MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that it has signed a new agreement with a global pharmaceutical company to support the commercial site transfer and commercial manufacturing of their branded specialty topical pharmaceutical product.

From MedPharm 5 Oct 2026